Home » Company

Company

Latest posts by investing (see all)
    Last Updated

    GlaxoSmithKline (NYSE:GSK)

    The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

    About GSK

    Financial Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    Related Articles

    Investing Articles

    What’s going on with the Unilever and GlaxoSmithKline share prices?

    | James J. McCombie

    Why did Unilever's share price fall and GlaxoSmithKline's rise after news of a rejected £50bn takeover bid for the latter's…

    Read more »

    One pound coin
    Investing Articles

    2 high dividend stocks I think are cheap

    | Christopher Ruane

    These two blue chips have high yields but look like good value - I'm thinking of buying them in December.

    Read more »

    Investing Articles

    Can the GlaxoSmithKline (GSK) share price double your money?

    | James J. McCombie

    Buying GlaxoSmithKline (LSE: GSK) and reinvesting your dividends can build real wealth over time.

    Read more »

    Investing Articles

    Why GlaxoSmithKline plc And Vertu Motors Plc Look Like Star Buys

    | Peter Stephens

    These 2 stocks appear to be worth buying right now: GlaxoSmithKline plc (LON: GSK) and Vertu Motors Plc (LON: VTU)

    Read more »

    Investing Articles

    Why GlaxoSmithKline plc And Hutchison China MediTech Limited Are A Perfect Pairing

    | G A Chester

    G A Chester reckons pairing GlaxoSmithKline plc (LON:GSK) with Hutchison China MediTech Limited (LON:HCM) could be a smart move.

    Read more »

    Investing Articles

    Why GlaxoSmithKline plc Is Worth More Than 1,700p Per Share

    | Rupert Hargreaves

    GlaxoSmithKline plc (LON: GSK) is severely undervalued at present levels.

    Read more »

    Investing Articles

    4 Payout Plays To Plough Your Cash Into: BT Group plc, GlaxoSmithKline plc, Carillion plc And Barratt Developments PLC

    | Royston Wild

    Royston Wild explains why dividend hunters should check out BT Group plc (LON: BT.A), GlaxoSmithKline plc (LON: GSK), Carillion plc…

    Read more »

    Investing Articles

    Is It Time To Sell AstraZeneca plc And Buy GlaxoSmithKline plc?

    | Prabhat Sakya

    Should you be a contrarian when investing in AstraZeneca plc (LON:AZN) and GlaxoSmithKline plc (LON:GSK)?

    Read more »

    Investing Articles

    Are Vectura Group PLC And Circassia Pharmaceuticals PLC Better Buys Than GlaxoSmithKline plc?

    | Peter Stephens

    Should you add Vectura Group PLC (LON: VEC) and Circassia Pharmaceuticals PLC (LON: CIR) to your portfolio before GlaxoSmithKline plc…

    Read more »

    Investing Articles

    How Safe Is GlaxoSmithKline plc’s 6% Dividend Yield?

    | Rupert Hargreaves

    How safe is GlaxoSmithKline plc's (LON: GSK) dividend?

    Read more »